Immatics NV share price logo

Immatics NV Share Price

NASDAQ: IMTX

Small Cap

$11.13

-0.05

(-0.45%)

Live

as on

Immatics NV Stock Performance

as on April 23, 2026 at 1:12 am IST

  • Day's Low

    Day's High

    $11.15
    $11.30
    downward going graph

    -0.18%

    Downside

    1.53%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.94
    $12.41
    downward going graph

    64.60%

    Downside

    11.50%

    Upside

    downward going graph

Immatics NV share price movements today

Previous Close
$11.18
Open
$11.30
Volume
67.5K
Day's Low - High
$11.15 - $11.30
52 Week Low - High
$3.94 - $12.41

Immatics NV Historical Returns

1 Month Return
+ 18.56 %
3 Month Return
+ 10.15 %
1 Year Return
+ 158.8 %
3 Year Return
+ 50.27 %
5 Year Return
-10.99 %

Immatics NV Stock Fundamentals & Key Indicators

Check Immatics NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-1.75

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-172.9M

Revenue (TTM)

48.3M

Profit Margin

0.00%

Return On Equity TTM

-37.10%

Immatics NV vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immatics NV with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immatics NV image
Immatics NV
BUY$1.5B-10.99%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$41.2B123.87%131.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$111.1B102.14%28.532.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.5BNA128.255.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$79.2B52.39%18.0531.41%

Stock Returns calculator for Immatics NV Stock including INR - Dollar returns

The Immatics NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immatics NV investment value today

Current value as on today

₹2,83,636

Returns

₹1,83,636

(+183.64%)

Returns from Immatics NV Stock

₹1,57,639 (+157.64%)

Dollar Impact

₹25,997 (+26%)

Analyst Recommendation on Immatics NV Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Immatics NV. Average target price of $18.75

Immatics NV Share Price Target

Get share price movements and forecasts by analysts on Immatics NV.

What analysts predicted

40.64%UPSIDE

Target Price

$18.75

Current Price

$11.13

Analyzed by

14 Analysts

Target

$18.75

Immatics NV target price $18.75, a slight upside of 40.64% compared to current price of $11.13. According to 14 analysts rating.

Immatics NV Stock’s Investor Sentiment and Interest

Search interest for Immatics NV Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:9% versus previous 30 day period

Immatics NV Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
6
17
33
20
56
58
20
4
5
19
Gross Profit
-26
-18
-1
20
56
58
20
4
5
19
Operating Income
-33
-27
-13
-26
0
0
-35
-53
-54
-36
EBITDA
-24
-24
-10
-14
0
46
-37
-68
-47
-39
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
3
3
3
3
3
3
3
3
Income Before Tax
-26
-26
-1
-17
-2
43
-40
-71
-50
-27
Income Tax Expense
0
0
1
0
6
-1
0
-1
0
0
Net Income
-28
-28
-3
-19
-9
46
-43
-70
-50
-27
Net Profit Margin
-447.00%
-164.24%
-10.09%
-96.09%
-16.95%
79.75%
-214.48%
-1485.07%
-974.46%
-141.42%

Immatics NV Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4
20
38
39
182
58
163
48
Gross Profit
-34
-24
-43
-59
69
-70
163
48
Operating Income
-34
-33
-69
-86
29
-101
-38
-179
EBITDA
-31
-28
-207
-87
50
-88
34
-167
Interest Expense
0
0
0
0
1
0
0
0
Depreciation
2
3
4
5
6
7
12
12
Income Before Tax
-32
-32
-229
-93
42
-96
21
-190
Income Tax Expense
-2
0
0
1
4
-2
6
-1
Net Income
-35
-35
-278
-107
39
-105
15
-188
Net Profit Margin
-834.06%
-172.05%
-733.84%
-273.45%
21.71%
-179.63%
9.77%
-390.95%

Immatics NV Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-26
-3
-18
-8
44
-39
-70
-52
-35
Operating Cash Flow
79
-32
-33
-33
-58
-34
-39
-44
-57
Investing Cash Flow
59
-241
69
67
-47
46
64
122
-29
Financing Cash Flow
0
174
0
0
146
0
0
0
98
Change in Cash
135
-96
36
31
47
6
13
78
10

Immatics NV Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-32
-229
-93
37
-94
15
-188
Operating Cash Flow
70
-85
-81
100
18
-158
-169
Investing Cash Flow
-5
-15
7
-209
-31
-152
196
Financing Cash Flow
-1
207
-2
123
84
319
93
Change in Cash
63
104
-74
15
69
18
137

Global Institutional Holdings in Immatics NV

Funds
Holdings
Citadel Advisors Llc
1.28%
T. Rowe Price Investment Management,Inc.
14.45%
Woodline Partners LP
0.75%
Sphera Funds Management Ltd.
0.64%
Baker Bros Advisors LP
9.02%
See all

Insights on Immatics NV

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IMTX stock has moved up by 158.8%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -70.34M → -27.94M (in $), with an average increase of 60.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IMTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IMTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 4.73M → 19.76M (in $), with an average increase of 41.2% per quarter

About Immatics NV

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
OrganisationImmatics NV
HeadquartersPaul-Ehrlich-Strasse 15-19, Tübingen, Germany, 72076
IndustryBiotechnology
CEODr. Harpreet Singh Ph.D.
E-voting on sharesClick here to vote

Key Management of Immatics NV

Name

Title

Dr. Harpreet Singh Ph.D.

CEO, MD, Member of Management Board & Executive Director

Dr. Hans-Georg Rammensee Ph.D.

Co-Founder & Member of the Scientific Advisory Board

Mr. Steffen Walter Ph.D.

Chief Operations Officer

Mr. Ephraim Hofsäß M.Sc.

Vice President of SEC Reporting & Accounting

Mr. Edward A. Sturchio

General Counsel & Secretary

Dr. Carsten Reinhardt M.D., Ph.D.

Chief Development Officer

Dr. Venkat Ramanan Ph.D.

Chief Financial Officer

Ms. Amie Krause

Chief People Officer

Dr. Toni Weinschenk Ph.D.

Co-Founder & Chief Innovation Officer

Ms. Lauren Schroeder

Vice President of Marketing

FAQs

What is Immatics NV share price today?

Immatics NV share price today is $11.13 as on . Immatics NV share today touched a day high of $11.3 and a low of $11.15.

What is the 52 week high and 52 week low for Immatics NV share?

Immatics NV share touched a 52 week high of $12.41 on and a 52 week low of $3.94 on . Immatics NV stock price today i.e. is trending at $11.13,which is 10.31% down from its 52 week high and 182.49% up from its 52 week low.

What is Immatics NV's market capitalisation today?

Immatics NV market capitalisation is $0.00T as on .

How to invest in Immatics NV Stock (IMTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immatics NV on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immatics NV Shares that will get you 0.1348 shares as per Immatics NV share price of $11.13 per share as on April 22, 2026 at 7:42 pm IST.

What is the minimum amount required to buy Immatics NV Stock (IMTX) from India?

Indian investors can start investing in Immatics NV (IMTX) shares with as little as ₹93.775 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.75 in Immatics NV stock (as per the Rupee-Dollar exchange rate as on ). Based on Immatics NV share’s latest price of $11.13 as on April 22, 2026 at 7:42 pm IST, you will get 0.8985 shares of Immatics NV. Learn more about fractional shares .

What are the returns that Immatics NV has given to Indian investors in the last 5 years?

Immatics NV stock has given -10.99% share price returns and 23.44% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?